{"id":"https://openalex.org/W2916215499","doi":"https://doi.org/10.1158/1078-0432.ccr-18-3034","title":"Comparison of Biomarker Assays for EGFR : Implications for Precision Medicine in Patients with Glioblastoma","display_name":"Comparison of Biomarker Assays for EGFR : Implications for Precision Medicine in Patients with Glioblastoma","publication_year":2019,"publication_date":"2019-02-22","ids":{"openalex":"https://openalex.org/W2916215499","doi":"https://doi.org/10.1158/1078-0432.ccr-18-3034","mag":"2916215499","pmid":"https://pubmed.ncbi.nlm.nih.gov/30796037","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8291723"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-18-3034","doi":"https://doi.org/10.1158/1078-0432.ccr-18-3034","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-18-3034","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8291723","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew B. Lassman","raw_affiliation_strings":["1Department of Neurology & Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurology & Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046267092","display_name":"Lisa A. Roberts-Rapp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Roberts-Rapp","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Irina Sokolova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irina Sokolova","raw_affiliation_strings":["3Abbott Molecular, Inc., Des Plaines, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Abbott Molecular, Inc., Des Plaines, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102246381","display_name":"Minghao Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Minghao Song","raw_affiliation_strings":["3Abbott Molecular, Inc., Des Plaines, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Abbott Molecular, Inc., Des Plaines, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031259595","display_name":"Ekaterina V. Pestova","orcid":"https://orcid.org/0000-0001-8200-2621","observed_orcids":["https://orcid.org/0000-0001-8200-2621"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ekaterina Pestova","raw_affiliation_strings":["3Abbott Molecular, Inc., Des Plaines, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Abbott Molecular, Inc., Des Plaines, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108691500","display_name":"Rupinder K. Kular","orcid":"https://orcid.org/0009-0000-9840-6508","observed_orcids":["https://orcid.org/0009-0000-9840-6508"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rupinder Kular","raw_affiliation_strings":["3Abbott Molecular, Inc., Des Plaines, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Abbott Molecular, Inc., Des Plaines, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019051973","display_name":"Carolyn Mullen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn Mullen","raw_affiliation_strings":["3Abbott Molecular, Inc., Des Plaines, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Abbott Molecular, Inc., Des Plaines, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034559027","display_name":"Zheng Zha","orcid":"https://orcid.org/0000-0001-7497-2441","observed_orcids":["https://orcid.org/0000-0001-7497-2441"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zheng Zha","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101606912","display_name":"Xin L. Lu","orcid":"https://orcid.org/0000-0002-6612-8352","observed_orcids":["https://orcid.org/0000-0002-6612-8352"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Lu","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079146812","display_name":"Erica J. Gomez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica Gomez","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036645151","display_name":"Anahita Bhathena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anahita Bhathena","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059093147","display_name":"David Maag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Maag","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091750059","display_name":"Priya Kumthekar","orcid":"https://orcid.org/0000-0001-5923-0677","observed_orcids":["https://orcid.org/0000-0001-5923-0677"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priya Kumthekar","raw_affiliation_strings":["4Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010378038","display_name":"Hui Kong Gan","orcid":"https://orcid.org/0000-0001-7319-8546","observed_orcids":["https://orcid.org/0000-0001-7319-8546"]},"institutions":[{"id":"https://openalex.org/I196829312","display_name":"La Trobe University","ror":"https://ror.org/01rxfrp27","country_code":"AU","type":"education","lineage":["https://openalex.org/I196829312"]},{"id":"https://openalex.org/I4405265871","display_name":"Olivia Newton-John Cancer Research Institute","ror":"https://ror.org/05yncf830","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196829312","https://openalex.org/I4210158799","https://openalex.org/I4405265871"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Hui K. Gan","raw_affiliation_strings":["5Austin Health, Olivia Newton-John Cancer Research Institute, and La Trobe University, Melbourne, Victoria, Australia"],"raw_orcid":"https://orcid.org/0000-0001-7319-8546","affiliations":[{"raw_affiliation_string":"5Austin Health, Olivia Newton-John Cancer Research Institute, and La Trobe University, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I196829312","https://openalex.org/I4405265871"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078312966","display_name":"Andrew Mark Scott","orcid":"https://orcid.org/0000-0002-6656-295X","observed_orcids":["https://orcid.org/0000-0002-6656-295X"]},"institutions":[{"id":"https://openalex.org/I196829312","display_name":"La Trobe University","ror":"https://ror.org/01rxfrp27","country_code":"AU","type":"education","lineage":["https://openalex.org/I196829312"]},{"id":"https://openalex.org/I4405265871","display_name":"Olivia Newton-John Cancer Research Institute","ror":"https://ror.org/05yncf830","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196829312","https://openalex.org/I4210158799","https://openalex.org/I4405265871"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew M. Scott","raw_affiliation_strings":["5Austin Health, Olivia Newton-John Cancer Research Institute, and La Trobe University, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Austin Health, Olivia Newton-John Cancer Research Institute, and La Trobe University, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I196829312","https://openalex.org/I4405265871"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria Guseva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Guseva","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015092618","display_name":"Kyle D. Holen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle D. Holen","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033578335","display_name":"Peter J. Ansell","orcid":"https://orcid.org/0000-0002-4088-2840","observed_orcids":["https://orcid.org/0000-0002-4088-2840"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J. Ansell","raw_affiliation_strings":["2AbbVie, Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AbbVie, Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010891460","display_name":"Martin J. van den Bent","orcid":"https://orcid.org/0000-0001-5710-5127","observed_orcids":["https://orcid.org/0000-0001-5710-5127"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4210149908","display_name":"Erasmus MC Cancer Institute","ror":"https://ror.org/03r4m3349","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Martin J. van den Bent","raw_affiliation_strings":["6Erasmus MC Cancer Center, Rotterdam, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-5710-5127","affiliations":[{"raw_affiliation_string":"6Erasmus MC Cancer Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4210149908"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5057541817"],"corresponding_institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"],"apc_list":null,"apc_paid":null,"fwci":2.58,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.8928035,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"25","issue":"11","first_page":"3259","last_page":"3265"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9670000076293945},{"id":"https://openalex.org/keywords/egfr-amplification","display_name":"EGFR amplification","score":0.9909999966621399},{"id":"https://openalex.org/keywords/fluorescence-in-situ-hybridization","display_name":"fluorescence in situ hybridization","score":0.9150000214576721},{"id":"https://openalex.org/keywords/whole-exome-sequencing","display_name":"exome sequencing","score":0.9789999723434448},{"id":"https://openalex.org/keywords/rt-pcr","display_name":"RT-PCR","score":0.7820000052452087},{"id":"https://openalex.org/keywords/rna-sequencing","display_name":"RNA sequencing","score":0.902999997138977},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.9810000061988831},{"id":"https://openalex.org/keywords/egfr-mrna-expression","display_name":"EGFR mRNA expression","score":0.7540000081062317},{"id":"https://openalex.org/keywords/copy-number","display_name":"copy number","score":0.6100000143051147},{"id":"https://openalex.org/keywords/assay-concordance","display_name":"assay concordance","score":0.7630000114440918},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.843999981880188},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.9549999833106995}],"concepts":[{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.8121042251586914},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.7005976438522339},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6547501087188721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5454387068748474},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4622248411178589},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36831361055374146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36783361434936523},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.25761091709136963},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2420428991317749},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08796963095664978}],"mesh":[{"descriptor_ui":"D000073359","descriptor_name":"Exome Sequencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005784","descriptor_name":"Gene Amplification","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005820","descriptor_name":"Genetic Testing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017404","descriptor_name":"In Situ Hybridization, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D060888","descriptor_name":"Real-Time Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1158/1078-0432.ccr-18-3034","doi":"https://doi.org/10.1158/1078-0432.ccr-18-3034","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-18-3034","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:30796037","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30796037","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8291723","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8291723","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},{"id":"pmh:eur:oai:pure.eur.nl:publications/1b0ff6e9-0fa6-4c8e-8e30-2cef2a3a3eaa","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/1b0ff6e9-0fa6-4c8e-8e30-2cef2a3a3eaa","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 25(11), 3259 - 3265. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/1b0ff6e9-0fa6-4c8e-8e30-2cef2a3a3eaa","doi":null,"is_oa":false,"landing_page_url":"https://www.scopus.com/pages/publications/85066614955","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Lassman, A B, Roberts-Rapp, L, Sokolova, I, Song, M, Pestova, E, Kular, R, Mullen, C, Zha, Z, Lu, X, Gomez, E, Bhathena, A, Maag, D, Kumthekar, P, Gan, H K, Scott, A M, Guseva, M, Holen, K D, Ansell, P J & van den Bent, M J 2019, 'Comparison of biomarker assays for EGFR : Implications for precision medicine in patients with glioblastoma', Clinical Cancer Research, vol. 25, no. 11, pp. 3259-3265. https://doi.org/10.1158/1078-0432.CCR-18-3034","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8291723","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8291723","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1459511762","display_name":null,"funder_award_id":"NCT01800695","funder_id":"https://openalex.org/F4320309117","funder_display_name":"AbbVie"},{"id":"https://openalex.org/G2793661665","display_name":"Columbia University Minority/Underserved Site NCI Community Oncology Research Program","funder_award_id":"UG1CA189960","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8821041303","display_name":null,"funder_award_id":"#UL1RRO24992","funder_id":"https://openalex.org/F4320310181","funder_display_name":"Institute of Clinical and Translational Sciences"},{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000907135","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA091842","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000916142","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA013696","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"},{"id":"https://openalex.org/F4320310181","display_name":"Institute of Clinical and Translational Sciences","ror":"https://ror.org/01yc7t268"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1571595367","https://openalex.org/W1973071934","https://openalex.org/W2044930054","https://openalex.org/W2053154970","https://openalex.org/W2092692114","https://openalex.org/W2105100844","https://openalex.org/W2109816625","https://openalex.org/W2122769974","https://openalex.org/W2126817554","https://openalex.org/W2129597559","https://openalex.org/W2139473501","https://openalex.org/W2155933329","https://openalex.org/W2164777277","https://openalex.org/W2525616756","https://openalex.org/W2561710991","https://openalex.org/W2597490071","https://openalex.org/W2638853381","https://openalex.org/W2761234814","https://openalex.org/W2765250662","https://openalex.org/W2766906603","https://openalex.org/W2767423922","https://openalex.org/W2770147923","https://openalex.org/W2793831611","https://openalex.org/W2891035173","https://openalex.org/W2903359836","https://openalex.org/W2955247130","https://openalex.org/W6731090695"],"related_works":["https://openalex.org/W2608516045","https://openalex.org/W4250118400","https://openalex.org/W2037370208","https://openalex.org/W2946676363","https://openalex.org/W2057697565","https://openalex.org/W2767539952","https://openalex.org/W2324431858","https://openalex.org/W1985417291","https://openalex.org/W2009508220","https://openalex.org/W4409782437"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Patients":[2],"with":[3,67,162],"glioblastoma":[4],"(GBM)":[5],"have":[6],"a":[7,35,60],"poor":[8],"prognosis":[9],"and":[10,26,90,111,157,204],"are":[11,21,29],"in":[12,31,56,191,222],"desperate":[13],"need":[14],"of":[15,43,230],"better":[16],"therapies.":[17],"As":[18],"therapeutic":[19,37,241],"decisions":[20],"increasingly":[22],"guided":[23],"by":[24,47,123,153,166],"biomarkers,":[25],"EGFR":[27,45,65,81,97,118,149,163,193,199,219],"abnormalities":[28],"common":[30],"GBM,":[32],"thus":[33],"representing":[34],"potential":[36],"target,":[38],"we":[39,51],"systematically":[40],"evaluated":[41,52],"methods":[42,133],"assessing":[44,198],"amplification":[46,82,164,220],"multiple":[48],"assays.":[49,80],"Specifically,":[50],"correlation":[53],"among":[54,131],"fluorescence":[55],"situ":[57],"hybridization":[58],"(FISH),":[59],"standard":[61],"assay":[62],"for":[63,78,197,218,234],"detecting":[64],"amplification,":[66],"other":[68],"methods.":[69],"Experimental":[70],"Design:":[71],"Formalin-fixed,":[72],"paraffin-embedded":[73],"tumor":[74],"samples":[75],"were":[76,134,159],"used":[77,215],"all":[79],"was":[83,100,121,173,186],"detected":[84],"using":[85,102,136],"FISH":[86,167,178],"(N":[87],"=":[88,95,109,116,127,140,169,182],"206)":[89,110],"whole-exome":[91],"sequencing":[92,155],"(WES,":[93],"N":[94,108,115,126],"74).":[96],"mRNA":[98,150,200],"expression":[99,120,151,185,190,201,211],"measured":[101],"reverse":[103],"transcription-polymerase":[104],"chain":[105],"reaction":[106],"(RT-PCR,":[107,202],"transcriptome":[112],"profiling":[113],"(RNAseq,":[114],"64).":[117],"protein":[119,189,210],"determined":[122,135],"immunohistochemistry":[124],"(IHC,":[125],"34).":[128],"Significant":[129],"correlations":[130],"various":[132],"Cohen's":[137],"kappa":[138],"(\u03ba":[139,168,181],"0.61\u20130.80":[141],"defines":[142],"substantial":[143],"agreement)":[144],"or":[145],"R2":[146],"statistics.":[147],"Results:":[148],"levels":[152],"RNA":[154,184],"(RNAseq)":[156],"RT-PCR":[158],"highly":[160],"correlated":[161],"assessed":[165],"0.702).":[170],"High":[171],"concordance":[172],"also":[174],"observed":[175],"when":[176],"comparing":[177],"to":[179,188],"WES":[180],"0.739).":[183],"superior":[187],"delineating":[192],"amplification.":[194],"Conclusions:":[195],"Methods":[196],"RNAseq)":[203],"copy":[205],"number":[206],"(WES),":[207],"but":[208],"not":[209],"(IHC),":[212],"can":[213],"be":[214],"as":[216],"surrogates":[217],"(FISH)":[221],"GBM.":[223],"Collectively,":[224],"our":[225],"results":[226],"provide":[227],"enhanced":[228],"understanding":[229],"available":[231],"screening":[232],"options":[233],"patients,":[235],"which":[236],"may":[237],"help":[238],"guide":[239],"EGFR-targeted":[240],"approaches.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-03-02T00:00:00"}